Loading...
Immunohistochemistry for CCR4 C‐terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T‐cell leukemia/lymphoma
Mogamulizumab targets extracellular N‐terminal domain of CCR4, which is expressed in most adult T‐cell leukemia/lymphoma (ATL) cases. Recently, we reported that CCR4 C‐terminal gain‐of‐function mutations were frequent in ATL cases, and a subgroup with these mutations who were treated without allogen...
Na minha lista:
| Udgivet i: | J Pathol Clin Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7737778/ https://ncbi.nlm.nih.gov/pubmed/33022137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cjp2.180 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|